Ghisallo Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Ghisallo Capital Management LLC holds 10 biotech & pharma companies tracked by BioSniper, totaling $9.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$9.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ALUMIS INC. (ALMS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALMSALUMIS INC. | 100,000 | $2.2M |
| DNLIDenali Therapeutics Inc. | 100,000 | $1.9M |
| PCVXVaxcyte, Inc. | 25,000 | $1.5M |
| CADLCandel Therapeutics, Inc. | 200,000 | $980K |
| IRONDisc Medicine, Inc. | 10,000 | $639K |
| ROIVRoivant Sciences Ltd. | 19,500 | $540K |
| IXHLIncannex Healthcare Inc. | 162,855 | $489K |
| MPLTMapLight Therapeutics, Inc. | 20,000 | $407K |
| MANEVeradermics Incorporated | 5,000 | $316K |
| ZURAZura Bio Ltd | 25,000 | $149K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.